Cargando…

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19

Detalles Bibliográficos
Autores principales:	Huang, Wenhui, Wu, Qingxia, Chen, Zhuozhi, Xiong, Zhiyuan, Wang, Kun, Tian, Jie, Zhang, Shuixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521372/ https://www.ncbi.nlm.nih.gov/pubmed/32998036 http://dx.doi.org/10.1016/j.jinf.2020.09.027

Ejemplares similares

Clinical Features and Outcomes of Coronavirus Disease 2019 (COVID-19) Patients With Chronic Hepatitis B Virus Infection
por: Zhang, Bin, et al.
Publicado: (2020)

Unfavorable outcomes in pregnant patients with COVID-19
por: Huang, Wenhui, et al.
Publicado: (2020)

Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
por: Kayarat, Bhavana, et al.
Publicado: (2021)

Acute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger
por: Amaral, Alexandre Franco, et al.
Publicado: (2021)

Lomustine induced acute pulmonary toxicity in a pediatric medulloblastoma survivor
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2017)

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat
por: Greene, Talya, et al.
Publicado: (2022)

Social‐epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors
por: Song, Nan, et al.
Publicado: (2022)

Pulmonary aspiration in preschool children with cystic fibrosis
por: Clarke, D., et al.
Publicado: (2018)

Pulmonary Fibrosis Due to COVID-19 Pneumonia
por: Kayhan, Servet, et al.
Publicado: (2020)

Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery
por: Yan, Xiquan, et al.
Publicado: (2021)

Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study
por: Chen, Luyan, et al.
Publicado: (2020)

The indispensable role of chest CT in the detection of coronavirus disease 2019 (COVID-19)
por: Liu, Jing, et al.
Publicado: (2020)

How many patients with idiopathic pulmonary fibrosis are there in Brazil?
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge
por: You, Jingjing, et al.
Publicado: (2020)

Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs
por: Wu, Jun, et al.
Publicado: (2020)

Therapeutic potentials of fasudil in liver fibrosis
por: Xi, Yue, et al.
Publicado: (2021)

Thoracic ultrasound: Possible complementary criteria for the assessment of pulmonary fibrosis
por: Trovato, Guglielmo M., et al.
Publicado: (2014)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
por: Papiris, Spyros A., et al.
Publicado: (2019)

Monocyte as a prognostic marker in patients with idiopathic pulmonary fibrosis
por: Zhu, Shiping
Publicado: (2021)

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge
por: Prakash, Jay, et al.
Publicado: (2021)

Tailored Post-Acute Care Coordination for Survivors of Moderate to Severe COVID-19 Infection
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2022)

Do we need a common liver fibrosis index or etiology-related indices?
por: Hessien, Mohamed
Publicado: (2011)

Victims or survivors?
por: Alachkar, Mustafa
Publicado: (2016)

An underestimated tool for both cooling and circulatory support in cardiac arrest survivors developing severe hyperthermia
por: Papanikolaou, John, et al.
Publicado: (2022)

18-month mental health outcomes among survivors of severe COVID-19 in Wuhan, China
por: Zhou, Jin, et al.
Publicado: (2023)

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017)

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic
por: Faverio, P., et al.
Publicado: (2023)

Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China
por: Xu, Bo, et al.
Publicado: (2022)

Response to: Comment on “Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis”
por: Fan, Lichao, et al.
Publicado: (2019)

Infertility in Pediatric Cancer Survivors: A Necessary Evil or a Potentially Avoidable Sequel?
por: Torres-Roman, Smith, et al.
Publicado: (2016)

Melioidosis in Tsunami Survivors
por: Athan, Eugene, et al.
Publicado: (2005)

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection
por: Nayagam, Jeremy S, et al.
Publicado: (2021)

Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli
por: Tiryaki, Tarık Onur, et al.
Publicado: (2021)

C-Reactive protein role in assessing COVID-19 deceased geriatrics and survivors of severe and critical illness
por: Nori, Wassan
Publicado: (2022)

Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19
por: Zhang, Bin, et al.
Publicado: (2021)

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response
por: Cottin, Vincent, et al.
Publicado: (2011)

COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib
por: Caradec, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_boo5et0ou4v4gm0q0hc975g611